CHUN CHEN: Open Payments
NPI 1326704354 · MONTEREY PARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,979 in 130 payments from 31 companies in 2025. Trend: 2023 $2,341 · 2024 $2,982 · 2025 $2,979
Food & beverage: $2,979
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 10 | $277 |
| Axsome Therapeutics, Inc. | 8 | $246 |
| AstraZeneca Pharmaceuticals LP | 10 | $235 |
| Regeneron Healthcare Solutions, Inc. | 8 | $196 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $196 |
| Amgen Inc. | 10 | $190 |
| GlaxoSmithKline, LLC. | 8 | $181 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $145 |
| GENZYME CORPORATION | 3 | $135 |
| Aimmune Therapeutics, Inc. | 5 | $130 |
Products named: DUPIXENT, IBSRELA, Kerendia, Symbravo, NUCALA, XIFAXAN, VOQUEZNA, BREZTRI.
Industry payments across CA — which companies pay providers there.
